ECS Botanics Holdings Ltd. provided revenue guidance for the third quarter of fiscal year 2022. The expected revenue increase during the current quarter will highlight a 39% increase on the previous quarter (second quarter of fiscal year 2022: $1,434,000) and a 440% rise on the prior corresponding period (second quarter of fiscal year 2021: $371,000). It would also mark another consecutive quarter of growth for the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.018 AUD | 0.00% | 0.00% | -20.00% |
May. 17 | ECS Botanics Secures First B2C Medicinal Cannabis Contract | MT |
Feb. 27 | ECS Botanics Holdings Ltd Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 15.41M | |
-.--% | 339M | |
+24.69% | 239M | |
+11.34% | 224M | |
+37.50% | 178M | |
+141.20% | 137M | |
-42.86% | 121M | |
+31.91% | 119M | |
-47.38% | 113M | |
+3.85% | 87.08M |
- Stock Market
- Equities
- ECS Stock
- News ECS Botanics Holdings Ltd
- ECS Botanics Holdings Ltd Provides Revenue Guidance for the Third Quarter of Fiscal Year 2022